Abatacept is an immunosuppressant, which is used for the treatment of rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis, and FCGR3A can affect the response to abatacept treatment in rheumatoid arthritis (14). Here, FCGR3A is linked to juvenile idiopathic arthritis.